| Vial description: |
Serpin E2N1N-1I7I-7 |
| Category: |
primary antibody |
| Raised in: |
Rabbit |
| Clone: |
1 vial |
| Form: |
Affinity Purified |
| Reactivity: |
Human |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
P07093 |
| Application: |
Western Blot |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
SERPINE2 (Center) |
| Short name: |
anti-SERPINE2 (Center) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
clade E (nexin, member 2 (central) (Antibody to), plasminogen activator inhibitor classification 1), antibody to-serpin peptidase inhibitor |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
Extracellular, GDN and GDNPF and PI-7 and PI7 and PN-1 and PN1 and PNI, SERPINE2 and IDBG-644187 and ENSBTAG00000008717 and, SERPINE2 and IDBG-82303 and ENSG00000135919 and 5270, Serpine2 and IDBG-173051 and ENSMUSG00000026249 and 20720, clade E (nexin, glutamatergic and biological process this GO :0060291 and long-term synaptic potentiation and biological process this GO :0060384 and innervation and biological process this GO :0061108 and seminal vesicle epithelium development and biological process this GO :0090331 and negative regulation of platelet aggregation and biological process, heparin binding, member 2, plasminogen activator inhibitor type 1), this GO :0004867 and serine-type endopeptidase inhibitor activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005539 and glycosaminoglycan binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005829 and cytosol and cellular component this GO :0007596 and blood coagulation and biological process this GO :0008201 and heparin binding and molecular function this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0009611 and response to wounding and biological process this GO :0010466 and negative regulation of peptidase activity and biological process this GO :0010544 and negative regulation of platelet activation and biological process this GO :0010757 and negative regulation of plasminogen activation and biological process this GO :0010766 and negative regulation of sodium ion transport and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0010955 and negative regulation of protein processing and biological process this GO :0014067 and negative regulation of phosphatidylinositol 3-kinase signaling and biological process this GO :0021683 and cerebellar granular layer morphogenesis and biological process this GO :0030195 and negative regulation of blood coagulation and biological process this GO :0030308 and negative regulation of cell growth and biological process this GO :0030334 and regulation of cell migration and biological process this GO :0031012 and extracellular matrix and cellular component this GO :0031091 and platelet alpha granule and cellular component this GO :0031232 and extrinsic component of external side of plasma membrane and cellular component this GO :0031594 and neuromuscular junction and cellular component this GO :0032940 and secretion by cell and biological process this GO :0033363 and secretory granule organization and biological process this GO :0042177 and negative regulation of protein catabolic process and biological process this GO :0042628 and mating plug formation and biological process this GO :0045861 and negative regulation of proteolysis and biological process this GO :0045879 and negative regulation of smoothened signaling pathway and biological process this GO :0048505 and regulation of timing of cell differentiation and biological process this GO :0048711 and positive regulation of astrocyte differentiation and biological process this GO :0050974 and detection of mechanical stimulus involved in sensory perception and biological process this GO :0051966 and regulation of synaptic transmission, this GO :0004867 : serine-type endopeptidase inhibitor activity, this GO :0004867 : serine-type endopeptidase inhibitor activity and also this GO :0005102 : receptor binding and also this GO :0005515 : protein binding and also this GO :0005539 : glycosaminoglycan binding and also this GO :0008201 : heparin binding, this GO :0005102 : receptor binding, this GO :0005515 : protein binding, this GO :0005539 : glycosaminoglycan binding, this GO :0008201 : heparin binding, serpin peptidase inhibitor |
| Identity: |
8951 |
| Gene: |
SERPINE2 |
More about : SERPINE2 |
| Long gene name: |
serpin family E member 2 |
| Synonyms gene: |
PI7 |
| Synonyms gene name: |
clade E (nexin, clade E (nexin, member 2 , member 2 serpin peptidase inhibitor, plasminogen activator inhibitor type 1), plasminogen activator inhibitor type 1), serine (or cysteine) proteinase inhibitor |
| Synonyms: |
PN1 GDN PNI nexin |
| Synonyms name: |
glial-derived nexin 1 |
| Locus: |
2q36, 1 |
| Discovery year: |
1994-09-01 |
| GenBank acession: |
M17783 |
| Entrez gene record: |
5270 |
| Pubmed identfication: |
7665170 24172014 |
| RefSeq identity: |
NM_006216 |
| Classification: |
Serpin peptidase inhibitors |
| Havana BLAST/BLAT: |
OTTHUMG00000133163 |